Tenet Healthcare (THC) Tops Q2 EPS by 31c, Offers Q3 & FY Guidance

Go back to Tenet Healthcare (THC) Tops Q2 EPS by 31c, Offers Q3 & FY Guidance

Tenet Reports Results for the Second Quarter Ended June 30, 2015

August 3, 2015 4:05 PM EDT

Generated Adjusted EBITDA of $568 million, an increase of 23.5%, and Adjusted diluted EPS of $0.75 2015 Adjusted EBITDA Outlook raised $175 million to $2.225 to $2.325 billion Hospital segment patient revenue increased 6.9% on a same-hospital basis, with admissions increasing 1.7%, adjusted admissions increasing 2.3%, and revenue per adjusted admission increasing 4.5% Ambulatory segment revenue increased 6.9% on a pro forma same-facility system-wide basis, with cases increasing 6.8% and revenue per case increasing 0.1% Conifers EBITDA increased 36% to $60 million

DALLAS--(BUSINESS WIRE)-- Tenet Healthcare Corporation (NYSE:... More